INDP — Indaptus Therapeutics, Inc.

INDPIndaptus Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · indaptusrx.com

2.450USD+20.99%Mkt Cap: 277.44M USDP/E: —Last update: 2026-06-10

Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to pr…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

Indicators:|

Key Statistics

Company

Market Cap277.44M USD

Enterprise Value236.31M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-20.85M USD

Revenue/Share—

Last Price2.450 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees5

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.51

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B190.91

EPS (TTM)-7.29

EPS (Forward)-1.39

52W Range

0.92008% of range19.91

52W High19.91 USD

52W Low0.9200 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-661.54%

ROA-223.94%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-14.82M USD

CapEx (TTM)—

FCF Margin—

FCF Yield-3.88%

Net Debt-1.50M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.00

Current Ratio2.34

Quick Ratio1.60

Book Value/Sh0.0110 USD

Cash/Share0.0130 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateOct 30, 2020

Splits

Last Split1:28

Split DateJun 27, 2025

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.113.24M

Float3.24M

Insiders96.93%

Institutions0.08%

Short Interest

Short Ratio1.1d

Short % Float0.05%

Short % Out.0.05%

Shares Short60.12K

Short (prev mo.)52.56K

Technical

SMA 502.205 (+11.1%)

SMA 2002.659 (-7.8%)

Beta1.27

S&P 52W Chg22.64%

Avg Vol (30d)1.68M

Avg Vol (10d)4.91M

Technical Indicators

RSI (14)52.5

MACD0.1629

MACD Signal0.0508

MACD Hist.+0.1121

BB Upper3.699 USD

BB Middle1.902 USD

BB Lower0.1046 USD

BB Width189.00%

ATR (14)0.7357 USD

Vol Ratio (20d)0.62x